Patrick Donnelly
Stock Analyst at Citigroup
(3.63)
# 774
Out of 4,944 analysts
336
Total ratings
50.83%
Success rate
4.99%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Maintains: Buy | $34 → $42 | $34.35 | +22.27% | 2 | Aug 13, 2025 | |
| QDEL QuidelOrtho | Maintains: Buy | $50 → $40 | $26.20 | +52.67% | 5 | Aug 6, 2025 | |
| BRKR Bruker | Maintains: Neutral | $40 → $38 | $33.67 | +12.86% | 17 | Aug 4, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $150 → $200 | $155.00 | +29.03% | 21 | Jul 9, 2025 | |
| HOLX Hologic | Upgrades: Buy | $60 → $80 | $68.17 | +17.35% | 15 | Jul 9, 2025 | |
| ILMN Illumina | Downgrades: Sell | $85 → $80 | $100.15 | -20.12% | 17 | Jul 9, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $287.16 | +21.88% | 15 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $271.71 | +28.81% | 15 | May 2, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $290 → $215 | $174.13 | +23.47% | 9 | Apr 7, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 | $1,324.06 | +5.74% | 13 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $13.81 | +8.62% | 12 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $12.88 | +39.75% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $53.82 | +30.06% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $188.10 | +11.64% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $482.93 | +18.03% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $177.85 | +4.02% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $208.27 | +27.24% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $8.04 | +186.07% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $15.64 | +27.88% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $44.83 | +67.30% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $119.77 | +37.76% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $58.91 | -23.61% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $22.63 | +23.73% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $90.00 | +61.11% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $48.98 | +26.17% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $294.62 | +1.83% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.80 | +221.43% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $2.30 | +19.57% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $271.08 | -4.09% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $4.79 | +25.26% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $5.88 | +444.22% | 2 | Nov 30, 2018 |
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $34.35
Upside: +22.27%
QuidelOrtho
Aug 6, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $26.20
Upside: +52.67%
Bruker
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $33.67
Upside: +12.86%
Charles River Laboratories International
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $155.00
Upside: +29.03%
Hologic
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $68.17
Upside: +17.35%
Illumina
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $100.15
Upside: -20.12%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $287.16
Upside: +21.88%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $271.71
Upside: +28.81%
ICON Public Limited Company
Apr 7, 2025
Maintains: Buy
Price Target: $290 → $215
Current: $174.13
Upside: +23.47%
Mettler-Toledo International
Apr 7, 2025
Upgrades: Buy
Price Target: $1,400
Current: $1,324.06
Upside: +5.74%
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $13.81
Upside: +8.62%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $12.88
Upside: +39.75%
Mar 4, 2025
Maintains: Neutral
Price Target: $80 → $70
Current: $53.82
Upside: +30.06%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $188.10
Upside: +11.64%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $482.93
Upside: +18.03%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $177.85
Upside: +4.02%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $208.27
Upside: +27.24%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $8.04
Upside: +186.07%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $15.64
Upside: +27.88%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $44.83
Upside: +67.30%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $119.77
Upside: +37.76%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $58.91
Upside: -23.61%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $22.63
Upside: +23.73%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $90.00
Upside: +61.11%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $48.98
Upside: +26.17%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $294.62
Upside: +1.83%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.80
Upside: +221.43%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $2.30
Upside: +19.57%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $271.08
Upside: -4.09%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $4.79
Upside: +25.26%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $5.88
Upside: +444.22%